Paper22014161
Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.
Axelsen LN and 9 others. Br J Pharmacol, 2012. Cited by 26 papers, by iCite.
11 sourcespapers-2026-11-12-0.1.0
Cite this record
ConductScience Library. Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts. Papers, record 22014161. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/22014161
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Glucagon and a glucagon-GLP-1 dual-agonist increases cardiac performance with different metabolic effects in insulin-resistant hearts.
- PubMed
Topics18
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cardiotonic Agents | Major topic |
| Glucagon | Major topic |
| Glucagon-Like Peptide 1 | Major topic |
| Heart | Major topic |
| Insulin Resistance | Major topic |
| Peptides | Major topic |
| Adenosine Triphosphate | |
| Animals | |
| Blood Pressure | |
| Glucose | |
| Glycolysis | |
| HEK293 Cells | |
| Heart Rate | |
| Humans | |
| Male | |
| Oxidation-Reduction | |
| Palmitates | |
| Rats |
Source PubMed
References31
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 17174230 | Glucagon-like peptide-1 infusion improves left ventricular ejection fraction and functional status in patients with chronic heart failure. | J Card Fail | 2006 | https://conductscience.org/library/papers/17174230 | PubMed |
| 2 | 12464581 | Potential mechanisms and consequences of cardiac triacylglycerol accumulation in insulin-resistant rats. | Am J Physiol Endocrinol Metab | 2003 | https://conductscience.org/library/papers/12464581 | PubMed |
| 3 | 19681866 | Emerging cardiovascular actions of the incretin hormone glucagon-like peptide-1: potential therapeutic benefits beyond glycaemic control? | Br J Pharmacol | 2009 | https://conductscience.org/library/papers/19681866 | PubMed |
| 4 | 10234590 | A review of potential cardiovascular uses of intravenous glucagon administration. | J Clin Pharmacol | 1999 | https://conductscience.org/library/papers/10234590 | PubMed |
| 5 | 1757353 | Myocardial function and energy substrate metabolism in the insulin-resistant JCR:LA corpulent rat. | J Appl Physiol (1985) | 1991 | https://conductscience.org/library/papers/1757353 | PubMed |
| 6 | 16489128 | Direct effects of glucagon-like peptide-1 on myocardial contractility and glucose uptake in normal and postischemic isolated rat hearts. | J Pharmacol Exp Ther | 2006 | https://conductscience.org/library/papers/16489128 | PubMed |
| 7 | 16265509 | Therapy insight: heart disease and the insulin-resistant patient. | Nat Clin Pract Cardiovasc Med | 2005 | https://conductscience.org/library/papers/16265509 | PubMed |
| 8 | 11780125 | Superoxide activates mitochondrial uncoupling proteins. | Nature | 2002 | https://conductscience.org/library/papers/11780125 | PubMed |
| 9 | 17928588 | The physiology of glucagon-like peptide 1. | Physiol Rev | 2007 | https://conductscience.org/library/papers/17928588 | PubMed |
| 10 | 9278241 | Measurements of fatty acid and carbohydrate metabolism in the isolated working rat heart. | Mol Cell Biochem | 1997 | https://conductscience.org/library/papers/9278241 | PubMed |
| 11 | 18427132 | Cardioprotective and vasodilatory actions of glucagon-like peptide 1 receptor are mediated through both glucagon-like peptide 1 receptor-dependent and -independent pathways. | Circulation | 2008 | https://conductscience.org/library/papers/18427132 | PubMed |
| 12 | 17696565 | Pharmacologic therapy of chronic heart failure. | Am J Cardiovasc Drugs | 2007 | https://conductscience.org/library/papers/17696565 | PubMed |
| 13 | 4303624 | Activation of adenyl cyclase by glucagon in cat and human heart. | Circ Res | 1969 | https://conductscience.org/library/papers/4303624 | PubMed |
| 14 | 19540343 | The cardioprotective and inotropic components of the postconditioning effects of GLP-1 and GLP-1(9-36)a in an isolated rat heart. | Pharmacol Res | 2009 | https://conductscience.org/library/papers/19540343 | PubMed |
| 15 | 16024574 | Active metabolite of GLP-1 mediates myocardial glucose uptake and improves left ventricular performance in conscious dogs with dilated cardiomyopathy. | Am J Physiol Heart Circ Physiol | 2005 | https://conductscience.org/library/papers/16024574 | PubMed |
| 16 | 21060752 | Exendin-4 protects oxidative stress-induced β-cell apoptosis through reduced JNK and GSK3β activity. | J Korean Med Sci | 2010 | https://conductscience.org/library/papers/21060752 | PubMed |
| 17 | 20448207 | Glucagon-like peptide 1 prevents reactive oxygen species-induced endothelial cell senescence through the activation of protein kinase A. | Arterioscler Thromb Vasc Biol | 2010 | https://conductscience.org/library/papers/20448207 | PubMed |
| 18 | 7242704 | A pharmacological method to estimate the pKi of competitive inhibitors of agonist uptake processes in isolated tissues. | Naunyn Schmiedebergs Arch Pharmacol | 1981 | https://conductscience.org/library/papers/7242704 | PubMed |
| 19 | 4391663 | Effect of glucagon on cyclic 3',5'-AMP, phosphorylase activity and contractility of heart muscle of the rat. | Circ Res | 1970 | https://conductscience.org/library/papers/4391663 | PubMed |
| 20 | 15313949 | Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy. | Circulation | 2004 | https://conductscience.org/library/papers/15313949 | PubMed |
Cited by15
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 26 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40458047 | Obesity and heart failure: exploring the cardiometabolic axis. | Cardiovasc Res | 2025 | https://conductscience.org/library/papers/40458047 | PubMed |
| 38832935 | Glucagon-like peptide-1 increases heart rate by a direct action on the sinus node. | Cardiovasc Res | 2024 | https://conductscience.org/library/papers/38832935 | PubMed |
| 32967969 | Agonist-activated glucagon receptors are deubiquitinated at early endosomes by two distinct deubiquitinases to facilitate Rab4a-dependent recycling. | J Biol Chem | 2020 | https://conductscience.org/library/papers/32967969 | PubMed |
| 29576852 | ZP2495 Protects against Myocardial Ischemia/Reperfusion Injury in Diabetic Mice through Improvement of Cardiac Metabolism and Mitochondrial Function: The Possible Involvement of AMPK-FoxO3a Signal Pathway. | Oxid Med Cell Longev | 2018 | https://conductscience.org/library/papers/29576852 | PubMed |
| 25685700 | Cardiomyocyte glucagon receptor signaling modulates outcomes in mice with experimental myocardial infarction. | Mol Metab | 2015 | https://conductscience.org/library/papers/25685700 | PubMed |
| 25685695 | Glucagon signaling in the heart: Activation or inhibition? | Mol Metab | 2015 | https://conductscience.org/library/papers/25685695 | PubMed |
| 25157099 | Cardiomyocyte-specific loss of diacylglycerol acyltransferase 1 (DGAT1) reproduces the abnormalities in lipids found in severe heart failure. | J Biol Chem | 2014 | https://conductscience.org/library/papers/25157099 | PubMed |
| 24910203 | Impact of glucagon-like peptide-1 on myocardial glucose metabolism revisited. | Rev Endocr Metab Disord | 2014 | https://conductscience.org/library/papers/24910203 | PubMed |
| 24309637 | Drugs with dual-hormone action gain attention in diabetes field. | Nat Med | 2013 | https://conductscience.org/library/papers/24309637 | PubMed |
| 24147975 | Mitochondrial fatty acid oxidation alterations in heart failure, ischaemic heart disease and diabetic cardiomyopathy. | Br J Pharmacol | 2014 | https://conductscience.org/library/papers/24147975 | PubMed |
| 23478327 | Emerging combinatorial hormone therapies for the treatment of obesity and T2DM. | Nat Rev Endocrinol | 2013 | https://conductscience.org/library/papers/23478327 | PubMed |
| 23019069 | Unraveling oxyntomodulin, GLP1's enigmatic brother. | J Endocrinol | 2012 | https://conductscience.org/library/papers/23019069 | PubMed |
| 23011203 | Procedure for calculation of potency and efficacy for ligands acting on Gs- and Gi-coupled receptors. | Neurochem Res | 2012 | https://conductscience.org/library/papers/23011203 | PubMed |
| 22960075 | The glucagon-like peptide-1 receptor agonist Exendin 4 has a protective role in ischemic injury of lean and steatotic liver by inhibiting cell death and stimulating lipolysis. | Am J Pathol | 2012 | https://conductscience.org/library/papers/22960075 | PubMed |
| 22489621 | Secretin family (Class B) G protein-coupled receptors - from molecular to clinical perspectives. | Br J Pharmacol | 2012 | https://conductscience.org/library/papers/22489621 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/22014161
GET https://conductscience.org/api/papers/v1/22014161/references?page=2